BCAL Diagnostics is out to combat breast cancer with lipid biomarker blood test
BCAL Diagnostics Ltd (ASX:BDX)'s Dr John Hurrell gives an overview of the company's vision: to champion the early diagnosis and intervention of breast...
Source: proactiveinvestors.com.au